Nature

Influenza A Virus Genome Packaging and RNA Structure

Influenza A virus (IAV) possesses a segmented, negative-sense RNA genome comprising eight distinct viral RNA (vRNA) segments. These segments form ribonucleoprotein (RNP) complexes that are selectively ...
Business Wire

Twist Bioscience Launches Synthetic RNA Control for H5N1 Influenza A

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...
News Medical

AAHI awarded a $9.9 million project to develop prototype intranasal bivalent influenza RNA vaccine candidate

The Access to Advanced Health Institute (AAHI) announced today that it has been awarded a project agreement worth up to $9.9 million through the Medical CBRN Defense Consortium (MCDC) Other ...
Business Wire

Infectious Disease Research Institute Awarded BARDA Funding for Development of Intranasal Influenza RNA Vaccine

Funds for proof-of-concept of an RNA vaccine administered as a spray up the nose, eliminating the need for needles and syringes. The influenza vaccine will be developed on IDRI’s thermostable RNA ...
EurekAlert!

The Access to Advanced Health Institute announces $9.9m award to develop a nasal spray influenza RNA vaccine through phase 1 clinical trials

SEATTLE, Washington, February, 6, 2022 – The Access to Advanced Health Institute (AAHI) announced today that it has been awarded a project agreement worth up to $9.9 million through the Medical CBRN ...
HealthDay on MSN

Modified mRNA Influenza Vaccine Superior to Inactivated Influenza Vaccine

A quadrivalent nucleoside-modified messenger RNA influenza vaccine met superiority criteria compared with a licensed inactivated vaccine.